Cerevel Therapeutics Holdings, Inc.

Grantham, Mayo, Van Otterloo & Co. LLC

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/13/2024

Shares

508,838

Value ($000)

20,806

Weight

0.1%

2024 Q2 - 2024 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/13/2024	20,806	0.1%	508,838	6/30/2024